Replies to post #7359 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

What is your estimate of [Daxxify] therapeutic sales for the first couple of quarters?

$10-20M.

…when will daxify start selling in China?

Fosun will launch as soon as they get regulatory approval. China accepted Fosun’s BLA on 7/13/23, so the review has been ongoing for ten months and approval could come at any time now. (China’s NMPA does not have a specific target date analogous to a US PDUFA date.)